• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

Avista buys 50% stake in Vista Healthcare

  • Harriet Matthews
  • Harriet Matthews
  • 01 June 2020
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Avista Capital Partners has bought a 50% stake in Belgium-based online consumer health retailer Vista Healthcare, backing the company's buyout along with management and previous shareholders.

Company founder Yvan Vindevogel previously owned a 48% stake in the company, while Creafund owned 15%, with the rest owned by various families and private individuals.

A 45% stake will be held by the existing shareholders, with a management team of 20 owning a 5% stake, according to De Tijd.  Creafund, which invests via an evergreen fund structure, will continue to hold a stake in the company.

Vision Healthcare

  • DEAL:

    Buyout

  • VALUE:

    €305m

  • LOCATION:

    Kortrijk

  • SECTOR:

    Speciality retailers

  • FOUNDED:

    2017

  • TURNOVER:

    €135m

  • EBITDA:

    >€23m (est)

  • STAFF:

    280

According to a statement from buyside adviser Stibbe, the company is valued at €305m. This equates to an EBITDA multiple of nearly 13x, according to De Tijd.

The buyout will be the largest to take place in Belgium in 2020, topping software companies Mak-System and Corilus in deal value, according to Unquote Data. 

In December 2019, Unquote sister publication Mergermarket cited a report from De Tijd that Vindevogel was seeking a buyer for a 50% stake in the company, expecting the new partner would invest €50-100m. The company planned to use the proceeds to fund add-on acquisitions, according to the report.

US-based sponsor Avista plans to assist the company with its international expansion, focusing on the US, and will also support its growth via further investments and add-on acquisitions, according to a statement from Vision Healthcare. The statement added that Avista emerged as the winning bidder for the company due to its geographic presence in North America and its experience in healthcare investments.

The company's shareholders are prepared to commit more than €100m in additional capital to support Vision Healthcare's growth, according to a statement. The company is currently reviewing a number of add-on acquisitions.

Previous funding
Creafund sold 100% of the shares in its portfolio company Mylène to Vision Healthcare in January 2019, having acquired the cosmetic product producer in an MBO in October 2015. Creafund invested a significant portion of the proceeds from the sale into Vision Healthcare, according to a statement.

Company
Founded in 2017, Vision Healthcare is an online platform that sells healthcare, cosmetic self-care and over-the-counter (OTC) products directly to consumers. Vision Healthcare has grown via a number of add-on acquisitions since its establishment, including Mylène and VitaminExpress.

Vision Healthcare reports sales of €135m. Based in Kortrijk, the company employs 280 people.

People
Vision Healthcare
– Yvan Vindevogel (founder, CEO).
Avista Capital Partners – Dean Thompson (co-CEO).

Advisers
Equity
– Ropes & Gray (legal); Stibbe (legal).
Vendor
– Rothschild (M&A); Allen & Overy (legal).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • Benelux
  • Consumer
  • Belgium

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013